TY - JOUR
KW - Humans
KW - Child
KW - Infant
KW - Retrospective Studies
KW - *Pneumococcal Infections/complications
KW - *Pneumonia, Pneumococcal
KW - Patient Acceptance of Health Care
KW - *Otitis Media
KW - England
KW - Pneumococcal Vaccines
AU - S. Mohanty
AU - B. Podmore
AU - Cuñado Moral
AU - I. Matthews
AU - E. Sarpong
AU - A. Azpeitia
AU - N. Qizilbash
AD - Merck & Co., Inc, Center for Observational and Real-World Evidence (CORE), Rahway, New Jersey, United States of America.
OXON Epidemiology Ltd, Epidemiology & Statistics, Madrid, Spain.
MSD (UK) Ltd, Value, Access and Devolved Nations (VAD), London, United Kingdom.
Merck & Co., Inc., Real-world Data Analytics and Innovation (RDAI), Rahway, New Jersey, United States of America.
AN - 37018218
BT - PLoS One
C2 - PMC10075442 following competing interests: Salini Mohanty, Ian Matthews, and Eric Sarpong are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and may own stock/stock options in Merck & Co., Inc., Rahway, NJ, USA. Bélène Podmore, Ana Cuñado, Agueda Azpeitia, and Nawab Qizilbash are employees of OXON Epidemiology Ltd, Epidemiology & Statistics, Madrid, Spain, an independent contract research organization, that received funding from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA to design and conduct this study.
DO - 10.1371/journal.pone.0283084
DP - NLM
ET - 2023/04/06
LA - eng
M1 - 4
N1 - 1932-6203
Mohanty, Salini
Orcid: 0000-0001-7610-6467
Podmore, Bélène
Cuñado Moral, Ana
Orcid: 0000-0002-2028-0025
Matthews, Ian
Orcid: 0000-0001-6175-6512
Sarpong, Eric
Azpeitia, Agueda
Qizilbash, Nawab
Journal Article
Research Support, Non-U.S. Gov't
United States
PLoS One. 2023 Apr 5;18(4):e0283084. doi: 10.1371/journal.pone.0283084. eCollection 2023.
PY - 2023
SN - 1932-6203
EP - e0283084
T2 - PLoS One
TI - Healthcare resource utilisation and cost of pneumococcal disease from 2003 to 2019 in children ≤17 years in England
VL - 18
ER -